SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Seattle Biotech -- Ignore unavailable to you. Want to Upgrade?


To: Mike McFarland who wrote (1)2/6/2000 1:09:00 AM
From: Mike McFarland  Read Replies (1) | Respond to of 70
 
Hood venture finds lab space
(Leroy Hood's Institute for Systems Biology)
amcity.com
Hood resigned in December to start his independent, nonprofit institute, which he described as "an ideal medium for collaboration between diverse academic and private-sector interests, particularly high-tech industries."

The institute hasn't signed any corporate sponsorships yet, but "we're pretty far down the line on some that will be significant," Coffman said.



To: Mike McFarland who wrote (1)3/18/2000 12:27:00 AM
From: Mike McFarland  Read Replies (1) | Respond to of 70
 
<One to watch> Rosetta Inpharmatics

Rosetta --$115 million in an initial public offering.
genomics
Rosetta raised $108 million in private financing,
including $41 million this month.

Top shareholders--Vulcan Ventures and Agilent.

rii.com

Puget Sound Business Journal story, if the link
doesn't go dead...
amcity.com

Also, a story on Immnunex
amcity.com